Covered recipient · General Payments record
TEJAL KOTHARI SHAIKH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$997.79
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $583.51 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $154.61 | 9 |
| Novo Nordisk AS | $126.42 | 7 |
| PFIZER INC. | $124.84 | 6 |
| Exact Sciences Corporation | $60.86 | 2 |
| Abbott Laboratories | $23.22 | 1 |
| EISAI INC. | $20.31 | 1 |
| Phathom Pharmaceuticals, Inc. | $19.91 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.99 | 1 |
| Acerta Pharma LLC | $18.85 | 1 |
| Currax Pharmaceuticals LLC | $15.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.22 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125100382 | CMS |
| ABBVIE INC. | $27.44 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070265 | CMS |
| ABBVIE INC. | $4.95 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070267 | CMS |
| ABBVIE INC. | $8.01 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070269 | CMS |
| ABBVIE INC. | $4.38 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070271 | CMS |
| ABBVIE INC. | $29.07 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070273 | CMS |
| ABBVIE INC. | $26.03 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070275 | CMS |
| ABBVIE INC. | $7.18 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070277 | CMS |
| ABBVIE INC. | $16.64 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070279 | CMS |
| ABBVIE INC. | $30.91 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106070281 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.85 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104705861 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.99 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118036834 | CMS |
| Currax Pharmaceuticals LLC | $15.50 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089516168 | CMS |
| Eisai Inc. | $20.31 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785033 | CMS |
| Exact Sciences Corporation | $26.00 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114488420 | CMS |
| Exact Sciences Corporation | $34.86 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114488426 | CMS |
| Novo Nordisk Inc | $13.63 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096984919 | CMS |
| Novo Nordisk Inc | $20.26 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096929208 | CMS |
| Novo Nordisk Inc | $17.93 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096570052 | CMS |
| Novo Nordisk Inc | $14.06 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096577787 | CMS |
| Novo Nordisk Inc | $16.91 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097631756 | CMS |
| Novo Nordisk Inc | $22.35 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097735881 | CMS |
| Novo Nordisk Inc | $21.28 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096817092 | CMS |
| PFIZER INC. | $24.66 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130987972 | CMS |
| PFIZER INC. | $26.35 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131052700 | CMS |
| PFIZER INC. | $19.14 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132019130 | CMS |
| PFIZER INC. | $19.11 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131449010 | CMS |
| PFIZER INC. | $16.98 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131743708 | CMS |
| PFIZER INC. | $18.60 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131964245 | CMS |
| Phathom Pharmaceuticals, Inc. | $19.91 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151124300 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.